Effect of combination of ezetimibe and a statin on coronary plaque regression in patients with acute coronary syndrome ZEUS trial (eZEtimibe Ultrasound Study)
Conclusions Additional LDL-C reduction with combination therapy tended to reduce more plaque regression compared to a statin alone in patients with ACS. In diabetic patients, further reduction of LDL-C was associated with a significantly greater reduction in PV.
Source: IJC Metabolic and Endocrine - Category: Endocrinology Source Type: research
More News: Atorvastatin Calcium | Cholesterol | Diabetes | Endocrinology | Lipitor | Statin Therapy | Statistics | Study | Ultrasound | Vytorin | Zetia | Zivast